All, n=308 | GA, n=153 | Non-GA, n=153 | P values | |
Valve type | ||||
Edwards Sapien | 168 (54.9) | 88 (57.5) | 80 (52.3) | 0.421 |
Medtronic CoreValve | 138 (45.1) | 65 (42.5) | 73 (47.7) | |
Delivery approach | ||||
Percutaneous | 282 (92.2) | 139 (90.8) | 143 (93.5) | 0.524 |
Surgical cut down | 24 (7.8) | 14 (9.2) | 10 (6.5) | |
Procedural imaging | ||||
Transoesophageal echocardiogram | 104 (34.0) | 52 (34.0) | 52 (34.0) | > 0.999 |
None or others | 202 (66.0) | 101 (66.0) | 101 (66.0) | |
Predeployment balloon valvuloplasty | 166 (54.2) | 86 (56.2) | 80 (52.3) | 0.566 |
Postdeployment balloon dilatation | 30 (9.9) | 13 (8.7) | 17 (11.1) | 0.565 |
Successful valve deployment | 291 (95.7) | 148 (96.7) | 143 (94.7) | 0.411 |
Aortic regurgitation at the end of the procedure, any degree | 151 (51.7) | 73 (49.3) | 78 (54.2) | 0.415 |
Aortic regurgitation at the end of the procedure, more than mild | 15 (5.1) | 5 (3.4) | 10 (6.9) | 0.193 |
Conversion to full sternotomy | 1 (0.3) | 0 (0.0) | 1 (0.6) | >0.999 |
Acute kidney injury within 7 days of the procedure | 17 (5.7) | 6 (4.0) | 11 (7.4) | 0.222 |
New dialysis before discharge | 3 (0.9) | 2 (1.2) | 1 (0.6) | 0.615 |
Tamponade during or after procedure | 4 (1.3) | 1 (0.7) | 3 (2.0) | 0.623 |
Cerebrovascular attack up to discharge | 8 (2.6) | 5 (3.3) | 3 (2.0) | 0.723 |
Major or life-threatening bleeding | 20 (6.6) | 11 (7.2) | 9 (6.0) | 0.818 |
Vascular access site complications | 34 (11.3) | 19 (12.4) | 15 (10.1) | 0.587 |
Procedure time (min) | 132.1±62.4 | 140±60.1 | 125±63.2 | 0.040 |
Length of stay in hospital (days) | 6.5±5.8 | 7.4±6.4 | 5.6±4.9 | 0.008 |
Values are mean±SD or n (%).
GA, general anaesthesia.